Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis

Journal of Infectious Diseases

Volumn 178, Issue 6, 1998, Pages 1750-1760

  Cenci, Elio ^a   Mencacci, Antonella ^a   D'Ostiani, Cristiana Fè ^a   Del Sero, Giuseppe ^a   Mosci, Paolo ^a   Montagnoli, Claudia ^a   Bacci, Angela ^a   Romani, Luigina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; ASPERGILLUS FUMIGATUS; CELLULAR IMMUNITY; FEMALE; HELPER CELL; HOST RESISTANCE; LUNG ASPERGILLOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA;

ANIMALS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; BRONCHOALVEOLAR LAVAGE FLUID; CYCLOPHOSPHAMIDE; CYTOKINES; EOSINOPHILS; FEMALE; GENE EXPRESSION REGULATION; IMMUNITY, MUCOSAL; INTERFERON TYPE II; INTERLEUKINS; LEUKOPENIA; LUNG; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED STRAINS; MONOCYTES; NEUTROPHILS; PHAGOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031768272     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314493     Document Type: Article

References (19)

1. Bodey GP, Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis 1989;8:413-37.
2. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:654-62.
3. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984;100:345-51.
4. Aisner J, Murillo J, Schmipff SC, Steere AC. Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotics use. Ann Intern Med 1979;90:4-9.
5. Gustafson TL, Schaffner W, Lavely GB, Stratton CW, Johnson HK, Hutcheson R. Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis 1983;14:230-8.
6. Rhodes JC. Aspergillosis. In: Murphy JW, Friedman H, Bendinelli M, eds. Fungal infections and immune responses. New York: Plenum Press, 1993:359-77.
7. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest 1982;69:617-31.
8. Waldorf AR, Levitz S, Diamond RD. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus famigatus. J Infect Dis 1984;150:752-60.
9. Levitz S, Selsted ME, Ganz T, Leher RI, Diamond RD. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dis 1986;154:483-9.
10. Dixon DM, Polak A, Walsh TJ. Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice. Infect Immun 1989;75:1452-6.
11. Dinauer MC. The respiratory burst oxidase and the molecular genetics of chronic granulomatous disease. Crit Rev Clin Lab Sci 1993;30:329-69.
12. Pollock JD, Williams DA, Gifford MAC, et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 1995;9:202-9.
13. Cohen MS, Isturiz RE, Malech HL, et al. Fungal infection in chronic granulomatous disease: the importance of the phagocytes in defense against fungi. Am J Med 1981;71:59-66.
14. Morgenstern DE, Gifford MAC, Li LL, Doerschuk CM, Dinauer MC. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med 1997;185:207-18.
15. Schnafler A. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J Clin Invest 1985;76:1755-64.
16. Palmer LB, Greenberg HE, Schiff M. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax 1991;46:15-20.
17. Weinberger M, Elattar I, Marshall D, et al. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine 1992;71:24-43.
18. Khoo, SH, Denning DW. Invasive Aspergillosis in patients with AIDS. J Infect Dis 1994;19(suppl 1):S41-8.
19. Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ. Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus. J Infect Dis 1993;167:905-11.